13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q2 2024 · Filed August 13, 2024 · Accession 0001012975-24-000321
Total Value
$130.1M
Positions
10
Other Managers
1
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 793,036 | $59.9M | 46.04% |
| 2 | INOZYME PHARMA INC | 45790W108 | 4,494,851 | $20.0M | 15.41% |
| 3 | OCULIS HOLDING AG | OCSAW | 1,595,918 | $19.1M | 14.66% |
| 4 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 2,041,108 | $19.0M | 14.59% |
| 5 | EXSCIENTIA PLC | 30223G102 | 770,500 | $3.9M | 3.02% |
| 6 | RALLYBIO CORP | RLYB | 2,404,644 | $3.2M | 2.48% |
| 7 | VIGIL NEUROSCIENCE INC | 92673K108 | 560,595 | $2.2M | 1.72% |
| 8 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,891,467 | $1.4M | 1.09% |
| 9 | IO BIOTECH INC | IOBT | 864,197 | $1.0M | 0.78% |
| 10 | ALIGOS THERAPEUTICS INC | ALGS | 743,215 | $260,125 | 0.20% |